Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04961749 · ClinicalTrials.gov registry record · NA

Retention of Whole-body Training Effects on Ambulatory Function in Children With Cerebral Palsy

A NA study, sponsored by University of Texas, El Paso.

Completed
Registry status
NA
Development phase
1
Enrollment target

NCT04961749: Completed NA study, sponsored by University of Texas, El Paso.

NCT04961749 is a NA study that has completed, run by University of Texas, El Paso. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04961749, a NA study, has completed, sponsored by University of Texas, El Paso.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

This study will evaluate the retention effects of a four-week whole-body vibration training intervention in children with Cerebral Palsy. The primary outcomes for this study are gait function, including Timed Up and Go and the two-minute walk test. Secondary outcomes of this study include lower extremity gait function, coordination, and gait variability. For this study, a total of 10 children with Cerebral Palsy (CP) will be recruited with 5 being randomly placed into an experimental group and 5 being randomly placed into a control group. Each participant, regardless of group, will complete pre-, post-, and retention testing, with a four-week whole-body vibration training intervention between the pre- and post-testing. The four-week whole-body vibration training will include three visits per week, with the experimental group receiving a vibration stimulus while standing on a vibration platform. Vibration sessions will consist of three-minutes of vibration, followed by three minutes rest, completing this cycle three separate times. The control group will follow a similar pattern, but rather than experiencing vibration, they will hear a sound of the vibration platform through a speaker. Once the four-week training session is finished, participants will return after a three-month retention period to determine whether ambulation function was retained.

Primary Outcome

Amount of time to quickly and safely complete the test

Interventions

  • OTHER Whole body vibration training

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2021-06-17
Est. Completion 2023-06-21
Phase NA
University of Texas, El Paso

17 total trials

What the finished NCT04961749 record still lists

NCT04961749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Whole body vibration training is the first listed.

NCT04961749 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04961749 about?

NCT04961749 is a clinical study titled "Retention of Whole-body Training Effects on Ambulatory Function in Children With Cerebral Palsy". This study will evaluate the retention effects of a four-week whole-body vibration training intervention in children with Cerebral Palsy. The primary outcomes for this study are gait function, including Timed Up and Go and the two-minute walk test. Secondary outcomes of this study include lower extr...

What is the current status of trial NCT04961749?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2021-06-17. Estimated completion is 2023-06-21.

What interventions are being tested in trial NCT04961749?

The interventions under investigation include: Whole body vibration training (OTHER).

Who is sponsoring clinical trial NCT04961749?

This trial is sponsored by University of Texas, El Paso, which has 17 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04961749's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04961749, the US trial registry maintained by the National Library of Medicine. NCT04961749 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.